Biomarkers to enhance accuracy and precision of prediction of short-term and long-term outcome after spontaneous intracerebral haemorrhage

A study protocol for a prospective cohort study

A. Kumar, P. Kumar, S. Misra, R. Sagar, P. Kathuria, D. Vibha, S. Vivekanandhan, A. Garg, B. Kaul, S. Raghvan, S. P. Gorthi, S. Dabla, C. S. Aggarwal, Kameshwar Prasad

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Several studies reported prognostic value of biomarker in intracerebral hemorrhagic (ICH) but they are either preliminary observation or inadequately powered to analyse independent contribution of biomarkers over and above clinical and neuroimaging data. Objective: To examine whether the biomarker can significantly add to the predictive accuracy of prognosis of ICH. Method/design: In a multi-centric prospective cohort study, 1020 patients with ICH within 72 hours of onset are being recruited. After obtaining written informed consent from patients/proxy, venous blood sample (10 ml) is being collected and analysed for C-reactive protein (CRP) level, S100B, Glial fibrillary acidic protein (GFAP), Troponin, change in leukocyte count and Copeptin levels. The patients are telephonically followed using stroke scales (Barthel Index and modified Rankin Scale) at 3, 6, 12 months and 2 years after the recruitment. Discussion: This protocol will aim at predicting the short term or long term prognosis with the use of clinical, neuroimaging and biomarkers in order to help clinician to stratify patients for early referral or intervention.

Original languageEnglish
Article number136
JournalBMC Neurology
Volume15
Issue number1
DOIs
Publication statusPublished - 12-08-2015

Fingerprint

Cerebral Hemorrhage
Cohort Studies
Biomarkers
Prospective Studies
Neuroimaging
Troponin
Glial Fibrillary Acidic Protein
Proxy
Informed Consent
Leukocyte Count
C-Reactive Protein
Referral and Consultation
Stroke
Observation

All Science Journal Classification (ASJC) codes

  • Clinical Neurology

Cite this

Kumar, A. ; Kumar, P. ; Misra, S. ; Sagar, R. ; Kathuria, P. ; Vibha, D. ; Vivekanandhan, S. ; Garg, A. ; Kaul, B. ; Raghvan, S. ; Gorthi, S. P. ; Dabla, S. ; Aggarwal, C. S. ; Prasad, Kameshwar. / Biomarkers to enhance accuracy and precision of prediction of short-term and long-term outcome after spontaneous intracerebral haemorrhage : A study protocol for a prospective cohort study. In: BMC Neurology. 2015 ; Vol. 15, No. 1.
@article{3d102f0f00844e37a2dbfe090683d640,
title = "Biomarkers to enhance accuracy and precision of prediction of short-term and long-term outcome after spontaneous intracerebral haemorrhage: A study protocol for a prospective cohort study",
abstract = "Background: Several studies reported prognostic value of biomarker in intracerebral hemorrhagic (ICH) but they are either preliminary observation or inadequately powered to analyse independent contribution of biomarkers over and above clinical and neuroimaging data. Objective: To examine whether the biomarker can significantly add to the predictive accuracy of prognosis of ICH. Method/design: In a multi-centric prospective cohort study, 1020 patients with ICH within 72 hours of onset are being recruited. After obtaining written informed consent from patients/proxy, venous blood sample (10 ml) is being collected and analysed for C-reactive protein (CRP) level, S100B, Glial fibrillary acidic protein (GFAP), Troponin, change in leukocyte count and Copeptin levels. The patients are telephonically followed using stroke scales (Barthel Index and modified Rankin Scale) at 3, 6, 12 months and 2 years after the recruitment. Discussion: This protocol will aim at predicting the short term or long term prognosis with the use of clinical, neuroimaging and biomarkers in order to help clinician to stratify patients for early referral or intervention.",
author = "A. Kumar and P. Kumar and S. Misra and R. Sagar and P. Kathuria and D. Vibha and S. Vivekanandhan and A. Garg and B. Kaul and S. Raghvan and Gorthi, {S. P.} and S. Dabla and Aggarwal, {C. S.} and Kameshwar Prasad",
year = "2015",
month = "8",
day = "12",
doi = "10.1186/s12883-015-0384-3",
language = "English",
volume = "15",
journal = "BMC Neurology",
issn = "1471-2377",
publisher = "BioMed Central",
number = "1",

}

Kumar, A, Kumar, P, Misra, S, Sagar, R, Kathuria, P, Vibha, D, Vivekanandhan, S, Garg, A, Kaul, B, Raghvan, S, Gorthi, SP, Dabla, S, Aggarwal, CS & Prasad, K 2015, 'Biomarkers to enhance accuracy and precision of prediction of short-term and long-term outcome after spontaneous intracerebral haemorrhage: A study protocol for a prospective cohort study', BMC Neurology, vol. 15, no. 1, 136. https://doi.org/10.1186/s12883-015-0384-3

Biomarkers to enhance accuracy and precision of prediction of short-term and long-term outcome after spontaneous intracerebral haemorrhage : A study protocol for a prospective cohort study. / Kumar, A.; Kumar, P.; Misra, S.; Sagar, R.; Kathuria, P.; Vibha, D.; Vivekanandhan, S.; Garg, A.; Kaul, B.; Raghvan, S.; Gorthi, S. P.; Dabla, S.; Aggarwal, C. S.; Prasad, Kameshwar.

In: BMC Neurology, Vol. 15, No. 1, 136, 12.08.2015.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Biomarkers to enhance accuracy and precision of prediction of short-term and long-term outcome after spontaneous intracerebral haemorrhage

T2 - A study protocol for a prospective cohort study

AU - Kumar, A.

AU - Kumar, P.

AU - Misra, S.

AU - Sagar, R.

AU - Kathuria, P.

AU - Vibha, D.

AU - Vivekanandhan, S.

AU - Garg, A.

AU - Kaul, B.

AU - Raghvan, S.

AU - Gorthi, S. P.

AU - Dabla, S.

AU - Aggarwal, C. S.

AU - Prasad, Kameshwar

PY - 2015/8/12

Y1 - 2015/8/12

N2 - Background: Several studies reported prognostic value of biomarker in intracerebral hemorrhagic (ICH) but they are either preliminary observation or inadequately powered to analyse independent contribution of biomarkers over and above clinical and neuroimaging data. Objective: To examine whether the biomarker can significantly add to the predictive accuracy of prognosis of ICH. Method/design: In a multi-centric prospective cohort study, 1020 patients with ICH within 72 hours of onset are being recruited. After obtaining written informed consent from patients/proxy, venous blood sample (10 ml) is being collected and analysed for C-reactive protein (CRP) level, S100B, Glial fibrillary acidic protein (GFAP), Troponin, change in leukocyte count and Copeptin levels. The patients are telephonically followed using stroke scales (Barthel Index and modified Rankin Scale) at 3, 6, 12 months and 2 years after the recruitment. Discussion: This protocol will aim at predicting the short term or long term prognosis with the use of clinical, neuroimaging and biomarkers in order to help clinician to stratify patients for early referral or intervention.

AB - Background: Several studies reported prognostic value of biomarker in intracerebral hemorrhagic (ICH) but they are either preliminary observation or inadequately powered to analyse independent contribution of biomarkers over and above clinical and neuroimaging data. Objective: To examine whether the biomarker can significantly add to the predictive accuracy of prognosis of ICH. Method/design: In a multi-centric prospective cohort study, 1020 patients with ICH within 72 hours of onset are being recruited. After obtaining written informed consent from patients/proxy, venous blood sample (10 ml) is being collected and analysed for C-reactive protein (CRP) level, S100B, Glial fibrillary acidic protein (GFAP), Troponin, change in leukocyte count and Copeptin levels. The patients are telephonically followed using stroke scales (Barthel Index and modified Rankin Scale) at 3, 6, 12 months and 2 years after the recruitment. Discussion: This protocol will aim at predicting the short term or long term prognosis with the use of clinical, neuroimaging and biomarkers in order to help clinician to stratify patients for early referral or intervention.

UR - http://www.scopus.com/inward/record.url?scp=84938938596&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938938596&partnerID=8YFLogxK

U2 - 10.1186/s12883-015-0384-3

DO - 10.1186/s12883-015-0384-3

M3 - Article

VL - 15

JO - BMC Neurology

JF - BMC Neurology

SN - 1471-2377

IS - 1

M1 - 136

ER -